Q

Qiagen NV
D

QGEN

47.250
USD
-0.26
(-0.55%)
مغلق
حجم التداول
51,706
الربح لكل سهم
2
العائد الربحي
-
P/E
106
حجم السوق
10,501,643,250
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    A
    0.030
    (0.02%)
    152.570 USD
    BDX
    BDX
    -2.330
    (-0.97%)
    237.930 USD
    B
    BIO
    6.81
    (1.92%)
    360.83 USD
    D
    DGX
    -1.120
    (-0.73%)
    151.530 USD
    H
    HOLX
    0.785
    (1.12%)
    71.145 USD
    IDXX
    IDXX
    3.20
    (0.75%)
    430.30 USD
    ILMN
    ILMN
    -1.005
    (-0.71%)
    140.300 USD
    L
    LH
    -1.660
    (-0.68%)
    242.340 USD
    TMO
    TMO
    1.41
    (0.25%)
    574.31 USD
    المزيد
الأخبار
المقالات

العنوان: Qiagen NV

القطاع: Healthcare
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).